THE WHITE HOUSE
Office of the Press Secretary
PRESIDENT CLINTON NAMES SIX TO THE NATIONAL CANCER ADVISORY BOARD The President announced today his intent to appoint six
people to the National Cancer Advisory Board. They are as follows:
Barbara K. Rimer of Chapel Hill, North Carolina currently serves as chair of the National Cancer Advisory Board, where she has served as a member since November 3, 1994. She is also the director of cancer prevention, detection and control research at Duke Comprehensive Cancer Center, and she is a senior fellow at the Aging Center and the Center for Health Policy Research and Education at Duke University Medical Center. She is a tenured professor of community and family medicine at Duke University Medical Center and an adjunct associate professor at the Department of Health Behavior and Health Education at the University of North Carolina School of Public Health. She is the author of more than 150 publications on the prevention and early detection of cancer and has served as a member of numerous boards and committees relating to cancer research. Dr. Rimer earned a B.A. in 1970 and an M.P.H. in 1973, both from the University of Michigan. She earned a D.P.H. from the Johns Hopkins School of Hygiene and Public Health in 1981.
Richard J. Boxer of Milwaukee, Wisconsin is a professor in both the Department of Family and Community Medicine and the Health Policy Institute at the Medical College of Wisconsin. Previously, Dr. Boxer has served as chief of urology and associate chief of surgery at Sinai-Samaritan Medical Center, and as chief of urology and chairman of the Department of Surgery at St. Michael Hospital. He is the medical advisor to two prostate cancer foundations, and has won a national award for cancer research. He has lectured and written extensively on cancer of the prostate, kidney and bladder. Dr. Boxer was appointed to the National Board of Advisors of the National Institute of Diabetes, Digestive and Kidney Diseases. Dr. Boxer is a graduate of the University of Wisconsin in Madison and the University of Wisconsin Medical School. He serves on the Board of Directors of the University Wisconsin Medical Alumni Association.
Frederick P. Li of Brookline, Massachusetts, is one of the leaders and developers in the field of molecular epidemiology. He is currently a physician at Brigham and Women's Hospital and head of the Division of Cancer Epidemiology and Control at the Dana-Farber Cancer Institute. Additionally, he is a professor of medicine at Harvard Medical School and a professor of clinical cancer epidemiology at the Harvard School of Public Health. He currently serves as chair of the Prevention Committee of the Harvard Cooperative Oncology Group and as a member of the board of directors of the American Association for Cancer Research and the External Advisory Committee at the Yale Cancer Center. Dr. Li is the author of numerous reports and publications pertaining to cancer research. He earned a B.A. from New York University in 1960, an M.D. from the University of Rochester School of Medicine and Dentistry in 1965 and an M.A. from Georgetown University in 1969.
Ivor Royston of La Jolla, California is currently president and chief executive officer of the Sidney Kimmel Cancer Center in San Diego which emphasizes biological approaches to cancer therapy. The Center is focused on research and the acceleration of laboratory discovery to the development of new cancer therapies, such as gene, antibody, vaccine and cell therapy. Previously, Dr. Royston was director of the Clinical Immunology Program at the University of California at San Diego (UCSD) Cancer Center. He served as an associate professor of medicine in the Division of Hematology/Oncology at the UCSD School of Medicine from 1982 to 1990. In addition, Dr. Royston served as chief of the oncology section at the San Diego VA Medical Center. Dr. Royston served in the U.S. Public Health Service from 1972 to 1975. He earned a B.A. in 1967 and an M.D. in 1970 from Johns Hopkins University and completed post-doctoral training in internal medicine and medical oncology at Stanford University Medical Center.
Ellen L. Stovall of Gaithersburg, Maryland is currently the executive director of the National Coalition for Cancer Survivorship, a nonprofit cancer organization based in Silver Spring, Maryland which advocates issues that affect people with all types of cancer and enhances the quality of life for people with cancer and those who care for them. Ms. Stovall, a 25-year survivor of Hodgkin's Disease, has been a staunch advocate for quality of life issues that affect people with cancer and their families for over twenty years. Previously, Ms. Stovall has served as co-founder and vice president of the Greater Washington Coalition for Cancer Survivorship (1988-1990) and as a board member for the National Coalition for Cancer Research (1992-1994). She is a member of the Southwest Oncology Group Advisory Committee on Women's Health and serves on the board of advisors for a number of national cancer organizations, including the Industries Coalition Against Cancer.
Sandra Millon-Underwood, RN of Gurnee, Illinois is an associate professor at the University of Wisconsin - Milwaukee. She has also served as visiting professor at the University of Wisconsin - Madison and Michigan State University and as a consultant with the Southwestern Oncology Group. She is the author of numerous articles pertaining to cancer prevention and control among at-risk, disadvantaged, vulnerable, and underserved populations. She is a member of the Oncology Nursing Society, the National Black Nurses' Association and the National Black Leadership Initiative on Cancer and the American Cancer Society National Taskforce on Cancer in the Poor and Underserved, among others. Dr. Millon-Underwood earned a B.S. in nursing in 1975 and an M.S. in nursing in 1978, from Loyola University (Chicago, Illinois). She earned a Ph.D. in education and social policy from Northwestern University in 1987.
The National Cancer Advisory Board was created in 1971 to advise and assist the Director of the National Cancer Institute with respect to the National Cancer Program. Each year the Board submits a report to the President for transmittal to the Congress on the progress of the National Cancer Program. Support for the Board is provided by the National Cancer Institute.